Search

everythinglearnresearchcommunity

for

Search:↓

Topical immunotherapy with DPCP is most effective for certain alopecia areata types, with success linked to age and disease duration, and influenced by a gene polymorphism.

Alopecia Areata is an autoimmune condition causing hair loss with no cure and treatments that often don't work well.

Amitraz effectively treated sarcoptic mange in three alpacas.

Scalp cooling effectively prevents hair loss in breast cancer patients undergoing chemotherapy.

Most patients with frontal fibrosing alopecia are postmenopausal women, and treatments like finasteride and dutasteride can improve or stabilize the condition.

Tofacitinib is safe and effective for severe alopecia areata, but hair loss may return 2 months after stopping treatment.

Alopecia areata is likely an autoimmune disease with unclear triggers, involving various immune cells and molecules, and currently has no cure.

Too much Smad7 changes skin and hair development by breaking down a protein called β-catenin, leading to more oil glands and fewer hair follicles.

Keratin 17 is crucial for early hair strength and cell survival.

No single treatment is consistently effective for alopecia areata, and more research is needed.

The document concludes that assessing hair follicle damage due to cyclophosphamide in mice involves analyzing structural changes and suggests a scoring system for standardized evaluation.

Hirsutism is more linked to high androgen levels than acne or hair loss, and a mix of hormonal tests is best for diagnosis; certain treatments can reduce symptoms.

Hair loss in men treated best with early medication or transplant, new treatments researched.

New treatments for Alopecia Areata show promise but need to be more effective and affordable.

Treatments for permanent hair loss from scarring aim to stop further loss, not regrow hair, and vary by condition, with partial success common.

Male pattern baldness involves smaller hair follicles, larger oil glands, and other tissue changes, but not major blood supply issues.

All-trans retinoic acid causes hair loss by increasing TGF-β2 in hair follicle cells.

Alopecia areata is likely caused by a combination of genetic factors and immune system dysfunction, and may represent different diseases with various causes.

The Lexington LaserComb helped regrow hair in mice with a condition similar to human hair loss.

A gene mutation in mice causes hair loss, weak bones, and protein buildup, showing how protein processing issues can lead to diseases.

Some treatments, like corticosteroids and sensitizing agents, can help with alopecia areata, but more high-quality research is needed.

The document concludes that early recognition and treatment of primary cicatricial alopecia is crucial to prevent permanent hair loss.

Alisertib was found to be an effective and tolerable treatment for children with recurrent brain tumors.

A deficiency in the TTC7A gene causes immune problems, gut issues, and hair loss.

Environmental factors at different levels control hair stem cell activity, which could lead to new hair growth and alopecia treatments.

The document concludes that while there are various treatments for Alopecia Areata, there is no cure, and individualized treatment plans are essential due to varying effectiveness.

Most cases of Temporal Triangular Alopecia are found in early childhood and may be related to genetic conditions.

Dupilumab may cause hair loss in some patients with severe atopic dermatitis.

Despite progress in treatment, the exact cause of Alopecia areata is still unknown.

Different treatments for alopecia areata have varying success rates and side effects; intralesional steroids are most effective.